Welcome to Anavex Life Sciences Corp.

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company engaged in the development of novel drug candidates to treat Alzheimer’s disease, other CNS diseases and various types of cancer.


Anavex corporate presentation at Rodman & Renshaw 16th Annual Global Investment Conference on September 10, 2014


Equities.com speaks with Christopher Missling, PhD., President and CEO of Anavex.